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Phase III clinical trials on severe sepsis and septic shock published during the past
decade have failed to reveal the superiority of any therapeutic intervention on
mortality compared with evolving standards of care, with the exception of the Early-
Goal Directed Therapy reported in 2001. This viewpoint paper presents an analysis
of these studies in order to understand what lessons can be learned and proposes
perspectives for future study designs. A total of 102 studies were selected among
clinical trials published in the field of severe sepsis and septic shock from 2001 to
2013, based on the assessment of a therapeutic intervention and mortality as an
outcome. Studies were further selected according to randomized, controlled trial
(RCT) quality criteria and analysed according to reported data. Most (n = 61) were
excluded because they did not comply with RCT quality criteria or did not report
inclusion criteria or patient severity (n = 22). The 19 remaining studies were
categorized into three groups depending on whether the intervention assessed led to
better, worse, or equivalent outcomes. It appears that the mortality rate in the
control arm, ranging from 17% to 61%, impacted the results, with a benefit reported
in the studies with the highest rates. Both heterogeneous studied populations and
uncontrolled diversity of care among participating centres probably contributed to
discrepancies between studies assessing the same intervention. The new challenge
to enhance the probability of decreasing mortality rates should include a more
appropriate definition of sepsis based on more specific criteria involving biomarker
use and accurate patient phenotypes.
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